Get started
Author

Naveena Aloysia D’Cor

Observed names: N.A. D’Cor, Naveena Aloysia D'Cor, Naveena A. D'Cor, Naveena Aloysia D'Cor, Naveena D'Cor, Naveena D’Cor
ORCID: 0000-0002-2930-9322
Observed ORCID: 0000-0002-2930-9322
OpenAlex ID: A5089955237
Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trial
2023 · Joon Young Song, Won Suk Choi, et al. · EClinicalMedicine · 47
PDF
Changing sero-epidemiology of hepatitis A in Asia Pacific countries: A systematic review
2017 · Marissa Gripenberg, Naveena Aloysia D’Cor, et al. · International Journal of Infectious Diseases · 34
PDF
Effect of prophylactic or therapeutic administration of paracetamol on immune response to DTwP-HepB-Hib combination vaccine in Indian infants
2017 · Arijit Sil, Mandyam D. Ravi, et al. · Vaccine · 12
PDF
Safety and immunogenicity of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine in adults and children in Vellore, South India
2019 · Venkata Raghava Mohan, Santosh Raj, et al. · PLoS ONE · 8
Safety and immunogenicity of the killed bivalent (O1 and O139) whole-cell cholera vaccine in the Philippines
2017 · Maria Rosario Z. Capeding, Maria Liza Antoinette M. Gonzales, et al. · Human Vaccines & Immunotherapeutics · 8
Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: randomised, active-controlled, observer-blinded, phase 3 trial
2023 · Joon Young Song, Won Suk Choi, et al. · medRxiv · 6
PDF
Safety and immunogenicity of a new formulation of a pentavalent DTwP-HepB-Hib vaccine in healthy Indian infants–A randomized study
2023 · Naveena Aloysia D’Cor, Prashanth Siddaiah, et al. · PLoS ONE · 5
PDF
Accelerating Shigella vaccines: from decades of research to global access
2026 · Shiferaw Tesfaye Tilahun, Sun Bean Kim, et al. · Expert Review of Vaccines · 2
PDF
Clinical Review of Shanchol™ (a WHO pre-qualified oral cholera vaccine)
2016 · N.A. D’Cor, B.N. Patnaik · International Journal of Infectious Diseases · 2
PDF
Uptake likelihood assessment of oral cholera vaccine capsules: insights from stakeholder consultations in five countries
2025 · Dijana Spasenoska, Anna-Lea Kahn, et al. · BMC Public Health · 1
PDF
Bivalent oral cholera vaccine in participants aged 1 year and older in the Dominican Republic: A phase III, single-arm, safety and immunogenicity trial
2018 · Lina Cordero De Los Santos, Jesús Feris-Iglesias, et al. · Human Vaccines & Immunotherapeutics · 1
PDF
Hepatitis E virus seroprevalence in South Africa: a multi-site study among HIV-negative and HIV-positive adults and age-stratified children (2–17 Years)
2026 · Tarun Saluja, Nigus Telele, et al. · BMC Infectious Diseases
Hepatitis E virus seroprevalence in South Africa from a multi-site study among HIV-negative and HIV-positive adults and age-stratified children (2–17 Years)
2026 · Tarun Saluja, Nigus Telele, et al. · medRxiv
Safety and Immunogenicity of a Cholera Conjugate Vaccine in Healthy South Korean Adults: A Phase 1 Dose-Escalation Trial
2026 · Naveena Aloysia D'Cor, Dong-Gun Lee, et al. · SSRN Electronic Journal
Clinical review of world health organization (who) pre-qualified oral cholera vaccine
2016 · Naveena Aloysia D'Cor, Badri Narayan Patnaik
Works count: 15
Citation count: 126
H-index: 6
I10-index: 3
Year
Topic
Type